{"gene":"F2","run_date":"2026-04-28T17:46:03","timeline":{"discoveries":[{"year":1989,"finding":"X-ray crystal structure of human alpha-thrombin (at 1.9 Å resolution) complexed with D-Phe-Pro-Arg chloromethylketone revealed the characteristic trypsin-like fold with unique insertions: the Tyr60A-Pro60B-Pro60C-Trp60D loop restricts the active site cleft and explains poor binding of most natural proteinase inhibitors; a narrow active site cleft with hydrophobic cage (Ile174, Trp215, Leu99, His57, Tyr60A, Trp60D) accounts for specificity toward Arg-containing substrates; the Lys70-Glu80 loop forms part of the anionic fibrinogen-recognition exosite.","method":"X-ray crystallography at 1.92 Å resolution with Patterson search refinement (R = 0.171)","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 — high-resolution crystal structure with full refinement, foundational structural study","pmids":["2583108"],"is_preprint":false},{"year":1989,"finding":"Thrombin activates Protein C in a reaction dramatically enhanced by thrombomodulin on endothelial cell surfaces; the thrombin-thrombomodulin complex shifts thrombin's substrate specificity from procoagulant substrates (fibrinogen, platelets) to the anticoagulant protein C, establishing thrombomodulin as a cofactor that redirects thrombin activity.","method":"In vitro enzyme kinetics, endothelial cell surface binding assays, functional coagulation assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — reconstituted biochemical system with kinetic characterization, widely replicated","pmids":["2538457"],"is_preprint":false},{"year":1990,"finding":"Crystal structure of the recombinant hirudin-thrombin complex at 2.3 Å resolution showed that hirudin's NH2-terminal globular domain forms a parallel β-strand with thrombin residues Ser214–Glu217 near the active site (without occupying the specificity pocket), while the COOH-terminal extended domain makes extensive electrostatic interactions with thrombin's fibrinogen-recognition exosite (anion-binding exosite); 27 of 65 hirudin residues contact thrombin (10 ion pairs, 23 hydrogen bonds), explaining the extremely high affinity and specificity of this inhibitor.","method":"X-ray crystallography at 2.3 Å resolution","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 — high-resolution crystal structure, foundational inhibitor-binding mechanism study","pmids":["2374926"],"is_preprint":false},{"year":1991,"finding":"Molecular cloning of a functional human thrombin receptor (PAR1) by expression cloning in Xenopus oocytes revealed a novel proteolytic activation mechanism: thrombin cleaves the receptor's extracellular amino-terminal extension at LDPR/S (position R41), generating a new receptor amino terminus that functions as a tethered ligand to activate the receptor intramolecularly. A peptide mimicking this new amino terminus was a potent agonist for receptor and platelet activation, while uncleavable mutant receptors failed to respond to thrombin but remained responsive to the tethered-ligand peptide.","method":"cDNA expression cloning in Xenopus oocytes, site-directed mutagenesis of cleavage site, synthetic peptide agonist assays, platelet activation assays","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 — reconstitution in oocytes, mutagenesis validation, synthetic peptide confirmation; highly cited foundational study","pmids":["1672265"],"is_preprint":false},{"year":1991,"finding":"In a revised model of blood coagulation, thrombin (F2 product) activates Factor XI directly without requiring Factor XIIa; in the absence of cofactors, thrombin is more effective than Factor XIIa (kcat/Km = 1.6×10⁵ vs. 1.7×10⁴). Dextran sulfate enhances Factor XI activation by thrombin ~2000-fold, partly through autoactivation by Factor XIa. This establishes a feedback loop in which thrombin amplifies its own generation by activating Factor XI.","method":"In vitro enzyme kinetics with purified factors, comparison of Factor XIIa and thrombin activation efficiencies, cofactor enhancement assays","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 — quantitative in vitro kinetic reconstitution with purified components","pmids":["1652157"],"is_preprint":false},{"year":1993,"finding":"Crystal structure of human alpha-thrombin complexed with a 15-mer single-stranded DNA aptamer (GGTTGGTGTGGTTGG) at 2.9 Å resolution showed the DNA folds into a G-quartet structure and binds to the fibrinogen-recognition exosite of thrombin through ionic and hydrophobic interactions; the heparin-binding site of a symmetry-related molecule also contacts the DNA. Mutational analysis (Arg75→Glu) confirmed the fibrinogen exosite as the functionally relevant binding site, consistent with inhibition of fibrinogen clotting and platelet activation.","method":"X-ray crystallography at 2.9 Å resolution, site-directed mutagenesis (Arg75→Glu), functional platelet activation and fibrinogen clotting assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with mutagenesis validation of binding exosite","pmids":["8102368"],"is_preprint":false},{"year":1996,"finding":"TAFI (thrombin-activatable fibrinolysis inhibitor/plasma procarboxypeptidase B) is activated by thrombin-catalyzed proteolysis, but the thrombin-thrombomodulin complex is the physiologic activator. Thrombomodulin increases catalytic efficiency 1250-fold, primarily through increased kcat. Kinetic modeling defined a ternary thrombin-thrombomodulin-TAFI complex (Km for TAFI = 1.0 µM; Kd for thrombomodulin = 8.6 nM; kcat = 1.2 s⁻¹). Activated TAFI inhibits tPA-induced fibrinolysis at ~1 nM, establishing that thrombin (via thrombomodulin) directly down-regulates fibrinolysis through TAFI activation.","method":"In vitro enzyme kinetics with purified components, Km/Kd/kcat determination, fibrinolysis inhibition assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — quantitative biochemical reconstitution with full kinetic characterization","pmids":["8663147"],"is_preprint":false},{"year":1997,"finding":"Cloning and characterization of protease-activated receptor 3 (PAR3) as a second human thrombin receptor. PAR3 mediates thrombin-triggered phosphoinositide hydrolysis and is expressed in human bone marrow and mouse megakaryocytes. The receptor uses the same proteolytic tethered-ligand activation mechanism as PAR1, demonstrating that thrombin can signal through multiple receptor subtypes in a tissue-specific manner.","method":"Molecular cloning, expression in heterologous cells, phosphoinositide hydrolysis assay, Northern blot, PAR1 knockout mouse studies","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1–2 — cloning with functional reconstitution and genetic validation in knockout mice","pmids":["9087410"],"is_preprint":false},{"year":1998,"finding":"Cloning of protease-activated receptor 4 (PAR4), a fourth member of the PAR family activated by thrombin and trypsin. Thrombin cleaves PAR4 at Arg-47/Gly-48 to generate a tethered ligand; the R47A mutant abolished thrombin/trypsin responses but retained responsiveness to the tethered-ligand hexapeptide GYPGQV. COS cells transfected with PAR4 produced inositol triphosphate upon thrombin stimulation, confirming G-protein coupling.","method":"cDNA cloning from lymphoma library, heterologous expression in COS cells, inositol triphosphate assay, site-directed mutagenesis (R47A), synthetic peptide agonist assays, Northern blot","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — reconstitution with mutagenesis and synthetic peptide validation of cleavage-activation mechanism","pmids":["9618465"],"is_preprint":false},{"year":2007,"finding":"The rate and extent of thrombin generation profoundly determines fibrin clot structure: low thrombin concentrations produce thick fibrin fibers that are highly susceptible to fibrinolysis, while high thrombin concentrations produce thin fibers that are resistant to fibrinolysis. Abnormal patterns of thrombin generation produce clots with altered fibrin structure associated with increased bleeding or thrombosis risk, demonstrating that F2/thrombin concentration at gelation is a key determinant of clot mechanical properties and fibrinolytic susceptibility.","method":"In vitro fibrin clot formation assays with defined purified thrombin concentrations, turbidimetric fiber thickness measurement, fibrinolysis susceptibility assays","journal":"Blood reviews","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro biochemical assays with defined concentrations; review synthesizing multiple experimental studies","pmids":["17208341"],"is_preprint":false}],"current_model":"F2 (prothrombin) is a serine protease zymogen cleaved to thrombin, whose 1.9 Å crystal structure reveals a restricted active-site cleft and a distinct fibrinogen-recognition exosite; thrombin activates platelets and cells via proteolytic unmasking of tethered-ligand receptors PAR1, PAR3, and PAR4, amplifies coagulation by activating Factor XI and the prothrombinase complex, and is redirected by thrombomodulin to activate Protein C (anticoagulant) and TAFI (antifibrinolytic), while thrombin concentration at gelation directly determines fibrin clot architecture and fibrinolytic susceptibility."},"narrative":{"teleology":[{"year":1989,"claim":"Determination of the 1.9 Å crystal structure of alpha-thrombin established the structural basis for its restricted substrate specificity and identified the fibrinogen-recognition exosite, answering how thrombin achieves selectivity despite its trypsin-like fold.","evidence":"X-ray crystallography of human alpha-thrombin complexed with D-Phe-Pro-Arg chloromethylketone at 1.92 Å resolution","pmids":["2583108"],"confidence":"High","gaps":["Structural basis for cofactor-induced substrate switching (e.g., by thrombomodulin) not resolved","No structure of prothrombin zymogen to understand activation conformational changes"]},{"year":1989,"claim":"Demonstration that thrombomodulin redirects thrombin from procoagulant substrates to protein C activation established the cofactor-dependent switch between procoagulant and anticoagulant functions of thrombin.","evidence":"In vitro enzyme kinetics and endothelial cell surface binding assays measuring protein C activation ± thrombomodulin","pmids":["2538457"],"confidence":"High","gaps":["Structural mechanism by which thrombomodulin alters thrombin's active-site specificity was unknown","Relative contribution of the thrombomodulin pathway in vivo not quantified"]},{"year":1990,"claim":"The hirudin–thrombin co-crystal structure mapped the molecular determinants of ultra-high-affinity inhibition, revealing that the fibrinogen-recognition exosite serves as a general substrate/inhibitor docking platform distinct from the catalytic cleft.","evidence":"X-ray crystallography of recombinant hirudin–thrombin complex at 2.3 Å resolution","pmids":["2374926"],"confidence":"High","gaps":["Whether endogenous serpins exploit the same exosite for initial docking was unresolved","Dynamics of exosite engagement in solution not captured"]},{"year":1991,"claim":"Cloning of PAR1 and the discovery of the tethered-ligand mechanism revealed how thrombin converts a proteolytic event into transmembrane signaling, establishing the paradigm for protease-activated receptor biology.","evidence":"Expression cloning in Xenopus oocytes, cleavage-site mutagenesis, and synthetic tethered-ligand peptide agonist assays","pmids":["1672265"],"confidence":"High","gaps":["Existence of additional thrombin receptor subtypes not yet known","Downstream G-protein coupling specificity of PAR1 not fully characterized"]},{"year":1991,"claim":"Demonstration that thrombin directly activates Factor XI more efficiently than Factor XIIa established a positive feedback loop through which thrombin amplifies its own generation independently of the contact pathway.","evidence":"In vitro kinetic comparison of thrombin vs. Factor XIIa activation of Factor XI with purified components","pmids":["1652157"],"confidence":"High","gaps":["Physiologic surface cofactors for thrombin-mediated Factor XI activation in vivo not identified","Relative contribution of this feedback loop versus the intrinsic pathway in different vascular beds unclear"]},{"year":1993,"claim":"The thrombin–DNA aptamer co-crystal structure confirmed the fibrinogen-recognition exosite as a druggable surface and revealed an unexpected G-quartet binding mode, providing a structural template for exosite-targeted inhibitor design.","evidence":"X-ray crystallography at 2.9 Å with Arg75→Glu mutagenesis confirming functional exosite engagement","pmids":["8102368"],"confidence":"High","gaps":["Whether aptamer binding fully occludes all exosite-dependent substrates was not tested","In vivo pharmacology of aptamer-mediated thrombin inhibition not assessed"]},{"year":1996,"claim":"Kinetic characterization of TAFI activation revealed that the thrombin–thrombomodulin complex is the physiologic activator (1250-fold efficiency increase), establishing a direct mechanistic link between thrombin generation and downregulation of fibrinolysis.","evidence":"Quantitative enzyme kinetics with purified thrombin, thrombomodulin, and TAFI; fibrinolysis inhibition assays","pmids":["8663147"],"confidence":"High","gaps":["Crystal structure of the ternary thrombin–thrombomodulin–TAFI complex not determined","Regulation of TAFI activation under flow conditions in vivo not addressed"]},{"year":1997,"claim":"Cloning of PAR3 as a second thrombin receptor extended the tethered-ligand paradigm to multiple receptor subtypes, indicating tissue-specific thrombin signaling.","evidence":"Molecular cloning, heterologous expression, phosphoinositide hydrolysis assays, and PAR1 knockout mouse studies","pmids":["9087410"],"confidence":"High","gaps":["Whether PAR3 functions as a signaling receptor or a cofactor for PAR4 in human platelets not resolved","PAR3 downstream signaling pathways incompletely characterized"]},{"year":1998,"claim":"Cloning and functional validation of PAR4 completed the inventory of thrombin-activated PARs, demonstrating a third receptor through which thrombin triggers G-protein-coupled signaling via tethered-ligand unmasking.","evidence":"cDNA cloning, COS cell expression, R47A mutagenesis abolishing thrombin response, synthetic GYPGQV peptide agonist","pmids":["9618465"],"confidence":"High","gaps":["Relative contributions of PAR1 vs. PAR4 to human platelet activation kinetics not quantified","Structural basis for differential thrombin affinity across PAR subtypes unknown"]},{"year":2007,"claim":"Establishing that thrombin concentration at the gelation point determines fibrin fiber diameter and fibrinolytic susceptibility linked thrombin generation dynamics directly to clot mechanical and lytic properties.","evidence":"In vitro fibrin clot formation with defined thrombin concentrations, turbidimetry, and fibrinolysis assays (review synthesizing multiple studies)","pmids":["17208341"],"confidence":"Medium","gaps":["Molecular mechanism by which thrombin concentration controls lateral fibrin protofibril association not defined","In vivo validation of concentration-dependent clot architecture under physiologic flow not performed","Role of other coagulation factors in modulating this relationship not isolated"]},{"year":null,"claim":"Key unresolved questions include the structural basis of the thrombomodulin-induced substrate specificity switch at atomic resolution, the contribution of prothrombin's kringle domains to its zymogen activation mechanism, and the relative signaling outputs of PAR1/PAR3/PAR4 in specific human vascular beds.","evidence":"","pmids":[],"confidence":"High","gaps":["No high-resolution structure of full-length prothrombin zymogen on a membrane surface","Integrated quantitative model of thrombin's substrate hierarchy in vivo lacking","PAR subtype-specific signaling in human vascular endothelium not systematically compared"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[1,3,4,6,7,8]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[0,3,4,6,8]},{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[3,7,8]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[0,1,4,6,9]}],"pathway":[{"term_id":"R-HSA-109582","term_label":"Hemostasis","supporting_discovery_ids":[0,1,4,5,6,9]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,7,8]}],"complexes":["Prothrombinase complex (Factor Xa/Va)","Thrombin–thrombomodulin complex"],"partners":["THBD","F2R","F2RL2","F2RL3","F11","CPB2","PROC","FGA"],"other_free_text":[]},"mechanistic_narrative":"Prothrombin (F2) is a serine protease zymogen that, upon cleavage to thrombin, serves as the central effector of the coagulation cascade and a multifunctional signaling protease whose substrate specificity is modulated by cofactors and whose concentration at gelation governs fibrin clot architecture. Thrombin's crystal structure reveals a trypsin-like fold with unique insertions—including the 60-loop that restricts the active-site cleft—and an anion-binding fibrinogen-recognition exosite critical for substrate and inhibitor engagement [PMID:2583108, PMID:2374926, PMID:8102368]. Thrombin activates platelets and other cells through proteolytic unmasking of tethered-ligand receptors PAR1, PAR3, and PAR4, and amplifies its own generation via a Factor XI feedback loop [PMID:1672265, PMID:9087410, PMID:9618465, PMID:1652157]. The thrombin–thrombomodulin complex redirects substrate specificity from procoagulant targets to protein C activation (anticoagulant) and TAFI activation (antifibrinolytic), while thrombin concentration at the point of gelation directly determines fibrin fiber thickness and fibrinolytic susceptibility [PMID:2538457, PMID:8663147, PMID:17208341]."},"prefetch_data":{"uniprot":{"accession":"P00734","full_name":"Prothrombin","aliases":["Coagulation factor II"],"length_aa":622,"mass_kda":70.0,"function":"Thrombin, which cleaves bonds after Arg and Lys, converts fibrinogen to fibrin and activates factors V, VII, VIII, XIII, and, in complex with thrombomodulin, protein C. Functions in blood homeostasis, inflammation and wound healing. Activates coagulation factor XI (F11); activation is promoted by the contact with negatively charged surfaces (PubMed:2019570, PubMed:21976677). Triggers the production of pro-inflammatory cytokines, such as MCP-1/CCL2 and IL8/CXCL8, in endothelial cells (PubMed:30568593, PubMed:9780208)","subcellular_location":"Secreted, extracellular space","url":"https://www.uniprot.org/uniprotkb/P00734/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/F2","classification":"Not Classified","n_dependent_lines":23,"n_total_lines":1208,"dependency_fraction":0.01903973509933775},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/F2","total_profiled":1310},"omim":[{"mim_id":"621543","title":"UBIQUITIN-ASSOCIATED PROTEIN 1-LIKE PROTEIN; UBAP1L","url":"https://www.omim.org/entry/621543"},{"mim_id":"621535","title":"SPINOCEREBELLAR ATAXIA 52; SCA52","url":"https://www.omim.org/entry/621535"},{"mim_id":"621424","title":"LEUKOENCEPHALOPATHY WITHOUT LACUNAE, ADULT-ONSET; LUCAO","url":"https://www.omim.org/entry/621424"},{"mim_id":"621349","title":"PEROXIREDOXIN-LIKE 2B; PRXL2B","url":"https://www.omim.org/entry/621349"},{"mim_id":"621125","title":"CILIARY DYSKINESIA, PRIMARY, 54; CILD54","url":"https://www.omim.org/entry/621125"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in single","driving_tissues":[{"tissue":"liver","ntpm":1138.4}],"url":"https://www.proteinatlas.org/search/F2"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P00734","domains":[{"cath_id":"2.40.20.10","chopping":"52-197","consensus_level":"medium","plddt":89.3003,"start":52,"end":197},{"cath_id":"2.40.20.10","chopping":"214-292","consensus_level":"medium","plddt":91.6213,"start":214,"end":292},{"cath_id":"2.40.10.10","chopping":"334-620","consensus_level":"medium","plddt":90.2657,"start":334,"end":620}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P00734","model_url":"https://alphafold.ebi.ac.uk/files/AF-P00734-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P00734-F1-predicted_aligned_error_v6.png","plddt_mean":83.94},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=F2","jax_strain_url":"https://www.jax.org/strain/search?query=F2"},"sequence":{"accession":"P00734","fasta_url":"https://rest.uniprot.org/uniprotkb/P00734.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P00734/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P00734"}},"corpus_meta":[{"pmid":"17949945","id":"PMC_17949945","title":"What is an epigenetic transgenerational phenotype? F3 or F2.","date":"2007","source":"Reproductive toxicology (Elmsford, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/17949945","citation_count":345,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16873254","id":"PMC_16873254","title":"Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice.","date":"2006","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/16873254","citation_count":249,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25140902","id":"PMC_25140902","title":"Influenza A virus protein PB1-F2 translocates into mitochondria via Tom40 channels and impairs innate immunity.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/25140902","citation_count":197,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11318969","id":"PMC_11318969","title":"Elevated plasma F2-isoprostanes in patients on long-term hemodialysis.","date":"2001","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/11318969","citation_count":187,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32013669","id":"PMC_32013669","title":"Influenza A virus protein PB1-F2 impairs innate immunity by inducing mitophagy.","date":"2020","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/32013669","citation_count":158,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17109325","id":"PMC_17109325","title":"The sorry state of F2 hybrids: consequences of rapid mitochondrial DNA evolution in allopatric populations.","date":"2006","source":"The American naturalist","url":"https://pubmed.ncbi.nlm.nih.gov/17109325","citation_count":156,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20661425","id":"PMC_20661425","title":"PB1-F2 proteins from H5N1 and 20 century pandemic influenza viruses cause immunopathology.","date":"2010","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/20661425","citation_count":136,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"6427411","id":"PMC_6427411","title":"Regional distribution of prostaglandins D2, E2, and F2 alpha and related enzymes in postmortem human brain.","date":"1984","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/6427411","citation_count":136,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17251572","id":"PMC_17251572","title":"Prevalence of PB1-F2 of influenza A viruses.","date":"2007","source":"The Journal of general virology","url":"https://pubmed.ncbi.nlm.nih.gov/17251572","citation_count":124,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"929121","id":"PMC_929121","title":"Levels of prostaglandins F2 alpha and E2 and thromboxane B2 in joint fluid in rheumatoid arthritis.","date":"1977","source":"Scandinavian journal of rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/929121","citation_count":120,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12695501","id":"PMC_12695501","title":"Prostaglandin F2(alpha) stimulates growth of skeletal muscle cells via an NFATC2-dependent pathway.","date":"2003","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/12695501","citation_count":119,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12164780","id":"PMC_12164780","title":"Identification of Drosophila melanogaster yellow-f and yellow-f2 proteins as dopachrome-conversion enzymes.","date":"2002","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/12164780","citation_count":114,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15514100","id":"PMC_15514100","title":"Plasma F2-isoprostanes and coronary artery calcification: the CARDIA Study.","date":"2004","source":"Clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15514100","citation_count":108,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8858591","id":"PMC_8858591","title":"Protein F2, a novel fibronectin-binding protein from Streptococcus pyogenes, possesses two binding domains.","date":"1996","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/8858591","citation_count":98,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17775172","id":"PMC_17775172","title":"Replication of the RNA of Bacteriophage f2.","date":"1966","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/17775172","citation_count":91,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15288129","id":"PMC_15288129","title":"Plasma F2-isoprostanes are elevated in newborns and inversely correlated to gestational age.","date":"2004","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15288129","citation_count":86,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22359544","id":"PMC_22359544","title":"Investigations on transgenerational epigenetic response down the male line in F2 pigs.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22359544","citation_count":86,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10454504","id":"PMC_10454504","title":"AL-8810: a novel prostaglandin F2 alpha analog with selective antagonist effects at the prostaglandin F2 alpha (FP) receptor.","date":"1999","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/10454504","citation_count":82,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20953627","id":"PMC_20953627","title":"Current knowledge on PB1-F2 of influenza A viruses.","date":"2010","source":"Medical microbiology and immunology","url":"https://pubmed.ncbi.nlm.nih.gov/20953627","citation_count":75,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8425493","id":"PMC_8425493","title":"Effects and interactions of prostaglandin F2 alpha, oxytocin, and cytokines on steroidogenesis of porcine luteal cells.","date":"1993","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/8425493","citation_count":75,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20660199","id":"PMC_20660199","title":"Differential localization and function of PB1-F2 derived from different strains of influenza A virus.","date":"2010","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/20660199","citation_count":75,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10405967","id":"PMC_10405967","title":"Elevated plasma levels of F2 alpha isoprostane in cystic fibrosis.","date":"1999","source":"Lipids","url":"https://pubmed.ncbi.nlm.nih.gov/10405967","citation_count":73,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9140048","id":"PMC_9140048","title":"Evidence for the distinct nature of F2-isoprostane receptors from those of thromboxane A2.","date":"1997","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/9140048","citation_count":71,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11285216","id":"PMC_11285216","title":"The hairpin structure of the (6)F1(1)F2(2)F2 fragment from human fibronectin enhances gelatin binding.","date":"2001","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/11285216","citation_count":69,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7707303","id":"PMC_7707303","title":"Control of endometrial oxytocin receptors and prostaglandin F2 alpha production in cows by progesterone and oestradiol.","date":"1995","source":"Journal of reproduction and fertility","url":"https://pubmed.ncbi.nlm.nih.gov/7707303","citation_count":66,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22050228","id":"PMC_22050228","title":"The influenza virus PB1-F2 protein has interferon antagonistic activity.","date":"2011","source":"Biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22050228","citation_count":65,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17224071","id":"PMC_17224071","title":"The PB1-F2 protein of Influenza A virus: increasing pathogenicity by disrupting alveolar macrophages.","date":"2007","source":"Virology journal","url":"https://pubmed.ncbi.nlm.nih.gov/17224071","citation_count":62,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21379324","id":"PMC_21379324","title":"Effect of 1918 PB1-F2 expression on influenza A virus infection kinetics.","date":"2011","source":"PLoS computational biology","url":"https://pubmed.ncbi.nlm.nih.gov/21379324","citation_count":61,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29374064","id":"PMC_29374064","title":"Forkhead Box F2 Suppresses Gastric Cancer through a Novel FOXF2-IRF2BPL-β-Catenin Signaling Axis.","date":"2018","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/29374064","citation_count":59,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17052982","id":"PMC_17052982","title":"Structural characterization and oligomerization of PB1-F2, a proapoptotic influenza A virus protein.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17052982","citation_count":57,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31617219","id":"PMC_31617219","title":"Paternal diet impairs F1 and F2 offspring vascular function through sperm and seminal plasma specific mechanisms in mice.","date":"2019","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31617219","citation_count":57,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28082325","id":"PMC_28082325","title":"Adapting Genotyping-by-Sequencing for Rice F2 Populations.","date":"2017","source":"G3 (Bethesda, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/28082325","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18005736","id":"PMC_18005736","title":"Influenza A virus PB1-F2: a small protein with a big punch.","date":"2007","source":"Cell host & microbe","url":"https://pubmed.ncbi.nlm.nih.gov/18005736","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29286299","id":"PMC_29286299","title":"Evolution and Virulence of Influenza A Virus Protein PB1-F2.","date":"2017","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29286299","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18772174","id":"PMC_18772174","title":"Endothelin-1 and F2-isoprostane relate to and predict renal dysfunction in hypertensive patients.","date":"2008","source":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association","url":"https://pubmed.ncbi.nlm.nih.gov/18772174","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"6134747","id":"PMC_6134747","title":"Topography of human uterine prostaglandin E and F2 alpha receptors and their profiles during pathological states.","date":"1983","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/6134747","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30529554","id":"PMC_30529554","title":"Antibacterial efficacy of a fucoidan fraction (Fu-F2) extracted from Sargassum polycystum.","date":"2018","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/30529554","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23717145","id":"PMC_23717145","title":"Enzymatic Biotransformation of Ginsenoside Rb1 and Gypenoside XVII into Ginsenosides Rd and F2 by Recombinant β-glucosidase from Flavobacterium johnsoniae.","date":"2012","source":"Journal of ginseng research","url":"https://pubmed.ncbi.nlm.nih.gov/23717145","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"5288771","id":"PMC_5288771","title":"Structure of the poly(G) polymerase component of the bacteriophage f2 replicase.","date":"1971","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/5288771","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20056670","id":"PMC_20056670","title":"Effect of prostaglandin F2 alpha on local luteotropic and angiogenic factors during induced functional luteolysis in the bovine corpus luteum.","date":"2010","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/20056670","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8399855","id":"PMC_8399855","title":"Prostaglandin F2 alpha receptor concentrations in corpora lutea of cycling, pregnant, and pseudopregnant pigs.","date":"1993","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/8399855","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8472854","id":"PMC_8472854","title":"Prostaglandin F2 alpha activates protein kinase C in human ovarian cells.","date":"1993","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/8472854","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21191105","id":"PMC_21191105","title":"Prostaglandin F2α stimulates PI3K/ERK/mTOR signaling and skeletal myotube hypertrophy.","date":"2010","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/21191105","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18390687","id":"PMC_18390687","title":"Two pathways for prostaglandin F2 alpha synthesis by the primate periovulatory follicle.","date":"2008","source":"Reproduction (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/18390687","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26311233","id":"PMC_26311233","title":"Hypoglycemic effects of Grifola frondosa (Maitake) polysaccharides F2 and F3 through improvement of insulin resistance in diabetic rats.","date":"2015","source":"Food & function","url":"https://pubmed.ncbi.nlm.nih.gov/26311233","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27106915","id":"PMC_27106915","title":"Ectoine and 5-hydroxyectoine accumulation in the halophile Virgibacillus halodenitrificans PDB-F2 in response to salt stress.","date":"2016","source":"Applied microbiology and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/27106915","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3859318","id":"PMC_3859318","title":"Prostaglandin F2 alpha in benign and malignant breast tumours.","date":"1985","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/3859318","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2159809","id":"PMC_2159809","title":"Control of bovine uterine prostaglandin F2 alpha release in vitro.","date":"1990","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/2159809","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21179467","id":"PMC_21179467","title":"Identification of genes and networks driving cardiovascular and metabolic phenotypes in a mouse F2 intercross.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21179467","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21167066","id":"PMC_21167066","title":"Genetic and genomic analysis of hyperlipidemia, obesity and diabetes using (C57BL/6J × TALLYHO/JngJ) F2 mice.","date":"2010","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/21167066","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15761081","id":"PMC_15761081","title":"Mapping and exclusion mapping of genomic imprinting effects in mouse F2 families.","date":"2005","source":"The Journal of heredity","url":"https://pubmed.ncbi.nlm.nih.gov/15761081","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34342980","id":"PMC_34342980","title":"Ginsenoside F2 Suppresses Adipogenesis in 3T3-L1 Cells and Obesity in Mice via the AMPK Pathway.","date":"2021","source":"Journal of agricultural and food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/34342980","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26708218","id":"PMC_26708218","title":"Transgenerational effects of obesity and malnourishment on diabetes risk in F2 generation.","date":"2015","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26708218","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"4318274","id":"PMC_4318274","title":"The metabolism of 2-furoic acid by Pseudomanas F2.","date":"1969","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/4318274","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21971186","id":"PMC_21971186","title":"The influenza A virus protein PB1-F2: killing two birds with one stone?","date":"2011","source":"Virulence","url":"https://pubmed.ncbi.nlm.nih.gov/21971186","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8473618","id":"PMC_8473618","title":"Intermodulation distortion (F2-F1) in inner hair cell and basilar membrane responses.","date":"1993","source":"The Journal of the Acoustical Society of America","url":"https://pubmed.ncbi.nlm.nih.gov/8473618","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28613140","id":"PMC_28613140","title":"Influenza virus protein PB1-F2 interacts with CALCOCO2 (NDP52) to modulate innate immune response.","date":"2017","source":"The Journal of general virology","url":"https://pubmed.ncbi.nlm.nih.gov/28613140","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25441581","id":"PMC_25441581","title":"Pregestational maternal obesity impairs endocrine pancreas in male F1 and F2 progeny.","date":"2014","source":"Nutrition (Burbank, Los Angeles County, Calif.)","url":"https://pubmed.ncbi.nlm.nih.gov/25441581","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2826898","id":"PMC_2826898","title":"Prostaglandin F2 alpha and oxytocin interactions in ovarian and uterine function.","date":"1987","source":"Journal of steroid biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2826898","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23704945","id":"PMC_23704945","title":"The influenza virus protein PB1-F2 interacts with IKKβ and modulates NF-κB signalling.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23704945","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"6246781","id":"PMC_6246781","title":"Hormone receptor control of prostaglandin F2 alpha secretion by the ovine uterus.","date":"1980","source":"Advances in prostaglandin and thromboxane research","url":"https://pubmed.ncbi.nlm.nih.gov/6246781","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2505758","id":"PMC_2505758","title":"Prostaglandins E2 and F2 alpha affect glycogen synthase and phosphorylase in isolated hepatocytes.","date":"1989","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/2505758","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18216117","id":"PMC_18216117","title":"Electron cryomicroscopy reveals different F1+F2 protein States in intact parainfluenza virions.","date":"2008","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/18216117","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11914123","id":"PMC_11914123","title":"Ca2+-mediated activation of ERK in hepatocytes by norepinephrine and prostaglandin F2 alpha: role of calmodulin and Src kinases.","date":"2002","source":"BMC cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11914123","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8804121","id":"PMC_8804121","title":"Negative regulatory activity of a prostaglandin F2 alpha receptor associated protein (FPRP).","date":"1996","source":"Prostaglandins, leukotrienes, and essential fatty acids","url":"https://pubmed.ncbi.nlm.nih.gov/8804121","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2172533","id":"PMC_2172533","title":"Comparison of oxytocin/prostaglandin F-2 alpha interrelationships in cyclic and pregnant cows.","date":"1990","source":"Journal of reproduction and fertility","url":"https://pubmed.ncbi.nlm.nih.gov/2172533","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25051456","id":"PMC_25051456","title":"Electrochemical detection of the oligomerization of PB1-F2 influenza A virus protein in infected cells.","date":"2014","source":"Analytical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25051456","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37666060","id":"PMC_37666060","title":"A large-scale transcriptional analysis reveals herb-derived ginsenoside F2 suppressing hepatocellular carcinoma via inhibiting STAT3.","date":"2023","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/37666060","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"5659846","id":"PMC_5659846","title":"The effects of prostaglandins E1, F1-alpha and F2-alpha on monosynaptic reflexes.","date":"1968","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/5659846","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16704986","id":"PMC_16704986","title":"Brassica vegetable consumption reduces urinary F2-isoprostane levels independent of micronutrient intake.","date":"2006","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/16704986","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32323899","id":"PMC_32323899","title":"Influenza A virus PB1-F2 protein: An ambivalent innate immune modulator and virulence factor.","date":"2020","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/32323899","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25385044","id":"PMC_25385044","title":"Oligomer procyanidins (F2) isolated from grape seeds inhibits tumor angiogenesis and cell invasion by targeting HIF-1α in vitro.","date":"2014","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/25385044","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26494255","id":"PMC_26494255","title":"Production of Ginsenoside F2 by Using Lactococcus lactis with Enhanced Expression of β-Glucosidase Gene from Paenibacillus mucilaginosus.","date":"2015","source":"Journal of agricultural and food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26494255","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"4943076","id":"PMC_4943076","title":"Inhibition of replication of ribonucleic acid bacteriophage f2 by superinfection with bacteriophage T4.","date":"1971","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/4943076","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16419158","id":"PMC_16419158","title":"Classifying genotype F of hepatitis B virus into F1 and F2 subtypes.","date":"2005","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/16419158","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29031029","id":"PMC_29031029","title":"Glutathione Peroxidase Activity, Plasma Total Antioxidant Capacity, and Urinary F2- Isoprostanes as Markers of Oxidative Stress in Anemic Dogs.","date":"2017","source":"Journal of veterinary internal medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29031029","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18337234","id":"PMC_18337234","title":"Prostaglandin F2-alpha receptor regulation in human uterine myocytes.","date":"2008","source":"Molecular human reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/18337234","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26068729","id":"PMC_26068729","title":"Schizophrenia-Like Phenotype Inherited by the F2 Generation of a Gestational Disruption Model of Schizophrenia.","date":"2015","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/26068729","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32866863","id":"PMC_32866863","title":"Maternal Bisphenol S exposure affects the reproductive capacity of F1 and F2 offspring in mice.","date":"2020","source":"Environmental pollution (Barking, Essex : 1987)","url":"https://pubmed.ncbi.nlm.nih.gov/32866863","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15200852","id":"PMC_15200852","title":"Influenza A virus PB1-F2 gene in recent Taiwanese isolates.","date":"2004","source":"Emerging infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/15200852","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2925947","id":"PMC_2925947","title":"Conception rates and calving intervals after prostaglandin F2 alpha or prebreeding progesterone in dairy cows.","date":"1989","source":"Journal of dairy science","url":"https://pubmed.ncbi.nlm.nih.gov/2925947","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19672555","id":"PMC_19672555","title":"Antibodies to PB1-F2 protein are induced in response to influenza A virus infection.","date":"2009","source":"Archives of virology","url":"https://pubmed.ncbi.nlm.nih.gov/19672555","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2307775","id":"PMC_2307775","title":"Inner hair cell responses to the 2f1-f2 intermodulation distortion product.","date":"1990","source":"The Journal of the Acoustical Society of America","url":"https://pubmed.ncbi.nlm.nih.gov/2307775","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12035975","id":"PMC_12035975","title":"The effect of estrogen receptor genotype on litter size and placental traits at term in F2 crossbred gilts.","date":"2002","source":"Theriogenology","url":"https://pubmed.ncbi.nlm.nih.gov/12035975","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24247765","id":"PMC_24247765","title":"Associations between quantitative traits and enzyme loci in the F2 population of a maize hybrid.","date":"1986","source":"TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik","url":"https://pubmed.ncbi.nlm.nih.gov/24247765","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33428928","id":"PMC_33428928","title":"The heme-binding protein PhuS transcriptionally regulates the Pseudomonas aeruginosa tandem sRNA prrF1,F2 locus.","date":"2021","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33428928","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7588230","id":"PMC_7588230","title":"Prostaglandin F2 alpha mediates ovarian sterol carrier protein-2 expression during luteolysis.","date":"1995","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/7588230","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9431817","id":"PMC_9431817","title":"Localization of the prostaglandin F2 alpha receptor in rat tissues.","date":"1997","source":"Prostaglandins, leukotrienes, and essential fatty acids","url":"https://pubmed.ncbi.nlm.nih.gov/9431817","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17737475","id":"PMC_17737475","title":"Cell Lysis: Another Function of the Coat Protein of the Bacteriophage f2.","date":"1968","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/17737475","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22043280","id":"PMC_22043280","title":"BID-F1 and BID-F2 domains of Bartonella henselae effector protein BepF trigger together with BepC the formation of invasome structures.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22043280","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23600872","id":"PMC_23600872","title":"PB1-F2 expedition from the whole protein through the domain to aa residue function.","date":"2013","source":"Acta virologica","url":"https://pubmed.ncbi.nlm.nih.gov/23600872","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7628355","id":"PMC_7628355","title":"Prostaglandin F2 alpha stimulates transforming growth factor-alpha expression in adipocyte precursors.","date":"1995","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/7628355","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7679982","id":"PMC_7679982","title":"Divergent actions of prostaglandins-E2 and -F2 alpha on the regulation of insulin-like growth factor-binding protein-3 in luteinized granulosa cells.","date":"1993","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/7679982","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35231598","id":"PMC_35231598","title":"Ammonium and hydroxylamine can be preferentially removed during simultaneous nitrification and denitrification by Pseudomonas taiwanensis EN-F2.","date":"2022","source":"Bioresource technology","url":"https://pubmed.ncbi.nlm.nih.gov/35231598","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29885348","id":"PMC_29885348","title":"Loading of doxorubicin and thymoquinone with F2 gel nanofibers improves the antitumor activity and ameliorates doxorubicin-associated nephrotoxicity.","date":"2018","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29885348","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32272772","id":"PMC_32272772","title":"Influenza PB1-F2 Inhibits Avian MAVS Signaling.","date":"2020","source":"Viruses","url":"https://pubmed.ncbi.nlm.nih.gov/32272772","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21239755","id":"PMC_21239755","title":"Functional polymorphisms of the coagulation factor II gene (F2) and susceptibility to systemic lupus erythematosus.","date":"2011","source":"The Journal of rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/21239755","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12893964","id":"PMC_12893964","title":"Inheritance of Oryza sativa endornavirus in F1 and F2 hybrids between japonica and indica rice.","date":"2003","source":"Genes & genetic systems","url":"https://pubmed.ncbi.nlm.nih.gov/12893964","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28291379","id":"PMC_28291379","title":"Characterization of VdASP F2 Secretory Factor from Verticillium dahliae by a Fast and Easy Gene Knockout System.","date":"2017","source":"Molecular plant-microbe interactions : MPMI","url":"https://pubmed.ncbi.nlm.nih.gov/28291379","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34896725","id":"PMC_34896725","title":"Evidence for the metal resistance of earthworm Eisenia fetida across generations (F1 and F2) under laboratory metal exposure.","date":"2021","source":"Journal of hazardous materials","url":"https://pubmed.ncbi.nlm.nih.gov/34896725","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20686565","id":"PMC_20686565","title":"Biological, clinical and population relevance of 95 loci for blood lipids.","date":"2010","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/20686565","citation_count":2873,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"1672265","id":"PMC_1672265","title":"Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation.","date":"1991","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/1672265","citation_count":2832,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8916933","id":"PMC_8916933","title":"A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.","date":"1996","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/8916933","citation_count":2518,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"24097068","id":"PMC_24097068","title":"Discovery and refinement of loci associated with lipid levels.","date":"2013","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24097068","citation_count":2409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12466191","id":"PMC_12466191","title":"Cellular actions of the insulin-like growth factor binding proteins.","date":"2002","source":"Endocrine reviews","url":"https://pubmed.ncbi.nlm.nih.gov/12466191","citation_count":1450,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10391209","id":"PMC_10391209","title":"Characterization of single-nucleotide polymorphisms in coding regions of human genes.","date":"1999","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10391209","citation_count":1381,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2538457","id":"PMC_2538457","title":"The roles of protein C and thrombomodulin in the regulation of blood coagulation.","date":"1989","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2538457","citation_count":927,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2583108","id":"PMC_2583108","title":"The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment.","date":"1989","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/2583108","citation_count":876,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9087410","id":"PMC_9087410","title":"Protease-activated receptor 3 is a second thrombin receptor in humans.","date":"1997","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/9087410","citation_count":761,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9618465","id":"PMC_9618465","title":"Cloning and characterization of human protease-activated receptor 4.","date":"1998","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9618465","citation_count":712,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2374926","id":"PMC_2374926","title":"The structure of a complex of recombinant hirudin and human alpha-thrombin.","date":"1990","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/2374926","citation_count":710,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15707890","id":"PMC_15707890","title":"PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells.","date":"2005","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/15707890","citation_count":664,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14718574","id":"PMC_14718574","title":"The human plasma proteome: a nonredundant list developed by combination of four separate sources.","date":"2004","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/14718574","citation_count":658,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"1652157","id":"PMC_1652157","title":"Factor XI activation in a revised model of blood coagulation.","date":"1991","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/1652157","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18976975","id":"PMC_18976975","title":"Genome-scale RNAi screen for host factors required for HIV replication.","date":"2008","source":"Cell host & microbe","url":"https://pubmed.ncbi.nlm.nih.gov/18976975","citation_count":627,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19362088","id":"PMC_19362088","title":"Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma.","date":"2009","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/19362088","citation_count":606,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7566121","id":"PMC_7566121","title":"Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor.","date":"1995","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/7566121","citation_count":572,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17208341","id":"PMC_17208341","title":"Thrombin generation and fibrin clot structure.","date":"2007","source":"Blood reviews","url":"https://pubmed.ncbi.nlm.nih.gov/17208341","citation_count":555,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8663147","id":"PMC_8663147","title":"TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8663147","citation_count":537,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2435757","id":"PMC_2435757","title":"Isolation of the thrombospondin membrane receptor.","date":"1987","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/2435757","citation_count":515,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8125298","id":"PMC_8125298","title":"Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides.","date":"1994","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/8125298","citation_count":492,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20351233","id":"PMC_20351233","title":"Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model.","date":"2010","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/20351233","citation_count":389,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12524220","id":"PMC_12524220","title":"The dynamics of thrombin formation.","date":"2003","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12524220","citation_count":387,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8102368","id":"PMC_8102368","title":"The structure of alpha-thrombin inhibited by a 15-mer single-stranded DNA aptamer.","date":"1993","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8102368","citation_count":377,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16335952","id":"PMC_16335952","title":"Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.","date":"2005","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/16335952","citation_count":350,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7989361","id":"PMC_7989361","title":"The mechanism of inactivation of human factor V and human factor Va by activated protein C.","date":"1994","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7989361","citation_count":347,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49797,"output_tokens":493,"usd":0.078393},"stage2":{"model":"claude-opus-4-6","input_tokens":3484,"output_tokens":512,"usd":0.04533},"total_usd":0.399624,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":62339,"output_tokens":3825,"usd":0.122196},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":6534,"output_tokens":2792,"usd":0.153705}},"stage1_raw":"Looking at the corpus, I need to identify which papers are about the human gene F2 (coagulation factor II / prothrombin). The corpus contains many papers about unrelated topics (influenza PB1-F2, prostaglandin F2-alpha biology, F2 generations in genetics studies, etc.). I need to find papers specifically about F2 = coagulation Factor II (prothrombin).\n\nOnly paper [97] directly addresses the human F2 gene (coagulation factor II/prothrombin), describing functional polymorphisms and their association with prothrombin activity levels. This is the only paper in the corpus that deals with the actual human F2 gene product (prothrombin).\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2011,\n      \"finding\": \"Two functional polymorphisms of the coagulation factor II gene (F2) — rs1799963 (G20210A) and rs3136516 (A19911G) — were shown to be associated with elevated prothrombin activity levels, as directly measured by prothrombin activity assays in carriers of the rs3136516 G allele among SLE patients.\",\n      \"method\": \"Prothrombin activity measurements in human subjects stratified by genotype, combined with allele frequency analysis in cases and controls\",\n      \"journal\": \"The Journal of rheumatology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single study, activity measurement in patient subset without in vitro reconstitution or mechanistic follow-up of how the variant alters prothrombin function\",\n      \"pmids\": [\"21239755\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"The F2 gene encodes prothrombin; functional polymorphisms (rs1799963 G20210A and rs3136516 A19911G) are associated with elevated prothrombin activity levels, but no detailed mechanistic studies of prothrombin's catalytic mechanism, structure, or binding partners were represented in the available literature corpus.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll systematically classify each paper before extracting discoveries.\n\n**F2 = human coagulation Factor II (prothrombin/thrombin gene)**\n\n**Classification of retrieved papers (100 main + 30 curated):**\n\nMost of the 100 retrieved papers are clearly NOT about human F2/prothrombin:\n- Papers about influenza PB1-F2 protein → EXCLUDE (different gene/protein)\n- Papers about F2-isoprostanes → EXCLUDE (lipid oxidation products, not the F2 gene)\n- Papers about transgenerational F2 generations → EXCLUDE (F2 = second filial generation)\n- Papers about prostaglandin F2alpha → EXCLUDE (prostanoid, not the F2 gene)\n- Papers about bacteriophage f2 → EXCLUDE (symbol collision, microbial)\n- Paper [14] about Streptococcus protein F2 → EXCLUDE (bacterial protein)\n- Paper [12] Drosophila yellow-f2 → EXCLUDE (symbol collision)\n- Papers about ginsenoside F2 → EXCLUDE (compound, not gene)\n- Various other non-F2 papers → EXCLUDE\n\n**KEEP from retrieved papers:**\n- Paper [97] (PMID:21239755): F2 functional polymorphisms and SLE — mentions prothrombin (F2 gene) encoded protein, functional polymorphisms affecting prothrombin activity. This is about the F2 gene but is primarily a genetic association/expression study → borderline, but does mention \"Prothrombin activity measurements\" showing higher activity with rs3136516 G allele. Mostly association study, minimal mechanistic content → EXCLUDE for mechanistic purposes.\n\n**KEEP from curated papers:**\n- PMID:1672265 — Molecular cloning of thrombin receptor, novel proteolytic activation mechanism (tethered ligand) → KEEP\n- PMID:8916933 — F2 G20210A variant, elevated prothrombin levels, thrombosis risk → association study, but establishes functional consequence of 3'UTR variant on prothrombin levels → mostly GWAS/association, EXCLUDE for mechanism\n- PMID:2583108 — Crystal structure of human alpha-thrombin → KEEP\n- PMID:9087410 — PAR3 as second thrombin receptor → KEEP\n- PMID:9618465 — PAR4 cloning, thrombin activation mechanism → KEEP\n- PMID:2374926 — Hirudin-thrombin complex structure → KEEP\n- PMID:2538457 — Protein C and thrombomodulin regulation of blood coagulation → KEEP\n- PMID:8663147 — TAFI activation by thrombin-thrombomodulin complex → KEEP\n- PMID:1652157 — Thrombin activates Factor XI (revised coagulation model) → KEEP\n- PMID:8102368 — Structure of thrombin-DNA aptamer complex → KEEP\n- PMID:7989361 — APC inactivation of Factor Va (thrombin substrate pathway) → this is about Factor V/Va and APC, not directly F2 mechanism → EXCLUDE (about Factor V)\n- PMID:15707890 — MMP-1 as PAR1 agonist → about PAR1, not F2 directly → EXCLUDE\n- PMID:12524220 — Dynamics of thrombin formation, tissue factor pathway → review of thrombin generation → mechanistic review → KEEP for context but limited new experimental findings\n- PMID:17208341 — Thrombin generation and fibrin clot structure → KEEP (thrombin concentration affects fibrin structure)\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1989,\n      \"finding\": \"X-ray crystal structure of human alpha-thrombin (at 1.9 Å resolution) complexed with D-Phe-Pro-Arg chloromethylketone revealed the characteristic trypsin-like fold with unique insertions: the Tyr60A-Pro60B-Pro60C-Trp60D loop restricts the active site cleft and explains poor binding of most natural proteinase inhibitors; a narrow active site cleft with hydrophobic cage (Ile174, Trp215, Leu99, His57, Tyr60A, Trp60D) accounts for specificity toward Arg-containing substrates; the Lys70-Glu80 loop forms part of the anionic fibrinogen-recognition exosite.\",\n      \"method\": \"X-ray crystallography at 1.92 Å resolution with Patterson search refinement (R = 0.171)\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution crystal structure with full refinement, foundational structural study\",\n      \"pmids\": [\"2583108\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1989,\n      \"finding\": \"Thrombin activates Protein C in a reaction dramatically enhanced by thrombomodulin on endothelial cell surfaces; the thrombin-thrombomodulin complex shifts thrombin's substrate specificity from procoagulant substrates (fibrinogen, platelets) to the anticoagulant protein C, establishing thrombomodulin as a cofactor that redirects thrombin activity.\",\n      \"method\": \"In vitro enzyme kinetics, endothelial cell surface binding assays, functional coagulation assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — reconstituted biochemical system with kinetic characterization, widely replicated\",\n      \"pmids\": [\"2538457\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"Crystal structure of the recombinant hirudin-thrombin complex at 2.3 Å resolution showed that hirudin's NH2-terminal globular domain forms a parallel β-strand with thrombin residues Ser214–Glu217 near the active site (without occupying the specificity pocket), while the COOH-terminal extended domain makes extensive electrostatic interactions with thrombin's fibrinogen-recognition exosite (anion-binding exosite); 27 of 65 hirudin residues contact thrombin (10 ion pairs, 23 hydrogen bonds), explaining the extremely high affinity and specificity of this inhibitor.\",\n      \"method\": \"X-ray crystallography at 2.3 Å resolution\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution crystal structure, foundational inhibitor-binding mechanism study\",\n      \"pmids\": [\"2374926\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"Molecular cloning of a functional human thrombin receptor (PAR1) by expression cloning in Xenopus oocytes revealed a novel proteolytic activation mechanism: thrombin cleaves the receptor's extracellular amino-terminal extension at LDPR/S (position R41), generating a new receptor amino terminus that functions as a tethered ligand to activate the receptor intramolecularly. A peptide mimicking this new amino terminus was a potent agonist for receptor and platelet activation, while uncleavable mutant receptors failed to respond to thrombin but remained responsive to the tethered-ligand peptide.\",\n      \"method\": \"cDNA expression cloning in Xenopus oocytes, site-directed mutagenesis of cleavage site, synthetic peptide agonist assays, platelet activation assays\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution in oocytes, mutagenesis validation, synthetic peptide confirmation; highly cited foundational study\",\n      \"pmids\": [\"1672265\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"In a revised model of blood coagulation, thrombin (F2 product) activates Factor XI directly without requiring Factor XIIa; in the absence of cofactors, thrombin is more effective than Factor XIIa (kcat/Km = 1.6×10⁵ vs. 1.7×10⁴). Dextran sulfate enhances Factor XI activation by thrombin ~2000-fold, partly through autoactivation by Factor XIa. This establishes a feedback loop in which thrombin amplifies its own generation by activating Factor XI.\",\n      \"method\": \"In vitro enzyme kinetics with purified factors, comparison of Factor XIIa and thrombin activation efficiencies, cofactor enhancement assays\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — quantitative in vitro kinetic reconstitution with purified components\",\n      \"pmids\": [\"1652157\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"Crystal structure of human alpha-thrombin complexed with a 15-mer single-stranded DNA aptamer (GGTTGGTGTGGTTGG) at 2.9 Å resolution showed the DNA folds into a G-quartet structure and binds to the fibrinogen-recognition exosite of thrombin through ionic and hydrophobic interactions; the heparin-binding site of a symmetry-related molecule also contacts the DNA. Mutational analysis (Arg75→Glu) confirmed the fibrinogen exosite as the functionally relevant binding site, consistent with inhibition of fibrinogen clotting and platelet activation.\",\n      \"method\": \"X-ray crystallography at 2.9 Å resolution, site-directed mutagenesis (Arg75→Glu), functional platelet activation and fibrinogen clotting assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with mutagenesis validation of binding exosite\",\n      \"pmids\": [\"8102368\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"TAFI (thrombin-activatable fibrinolysis inhibitor/plasma procarboxypeptidase B) is activated by thrombin-catalyzed proteolysis, but the thrombin-thrombomodulin complex is the physiologic activator. Thrombomodulin increases catalytic efficiency 1250-fold, primarily through increased kcat. Kinetic modeling defined a ternary thrombin-thrombomodulin-TAFI complex (Km for TAFI = 1.0 µM; Kd for thrombomodulin = 8.6 nM; kcat = 1.2 s⁻¹). Activated TAFI inhibits tPA-induced fibrinolysis at ~1 nM, establishing that thrombin (via thrombomodulin) directly down-regulates fibrinolysis through TAFI activation.\",\n      \"method\": \"In vitro enzyme kinetics with purified components, Km/Kd/kcat determination, fibrinolysis inhibition assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — quantitative biochemical reconstitution with full kinetic characterization\",\n      \"pmids\": [\"8663147\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Cloning and characterization of protease-activated receptor 3 (PAR3) as a second human thrombin receptor. PAR3 mediates thrombin-triggered phosphoinositide hydrolysis and is expressed in human bone marrow and mouse megakaryocytes. The receptor uses the same proteolytic tethered-ligand activation mechanism as PAR1, demonstrating that thrombin can signal through multiple receptor subtypes in a tissue-specific manner.\",\n      \"method\": \"Molecular cloning, expression in heterologous cells, phosphoinositide hydrolysis assay, Northern blot, PAR1 knockout mouse studies\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — cloning with functional reconstitution and genetic validation in knockout mice\",\n      \"pmids\": [\"9087410\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Cloning of protease-activated receptor 4 (PAR4), a fourth member of the PAR family activated by thrombin and trypsin. Thrombin cleaves PAR4 at Arg-47/Gly-48 to generate a tethered ligand; the R47A mutant abolished thrombin/trypsin responses but retained responsiveness to the tethered-ligand hexapeptide GYPGQV. COS cells transfected with PAR4 produced inositol triphosphate upon thrombin stimulation, confirming G-protein coupling.\",\n      \"method\": \"cDNA cloning from lymphoma library, heterologous expression in COS cells, inositol triphosphate assay, site-directed mutagenesis (R47A), synthetic peptide agonist assays, Northern blot\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with mutagenesis and synthetic peptide validation of cleavage-activation mechanism\",\n      \"pmids\": [\"9618465\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The rate and extent of thrombin generation profoundly determines fibrin clot structure: low thrombin concentrations produce thick fibrin fibers that are highly susceptible to fibrinolysis, while high thrombin concentrations produce thin fibers that are resistant to fibrinolysis. Abnormal patterns of thrombin generation produce clots with altered fibrin structure associated with increased bleeding or thrombosis risk, demonstrating that F2/thrombin concentration at gelation is a key determinant of clot mechanical properties and fibrinolytic susceptibility.\",\n      \"method\": \"In vitro fibrin clot formation assays with defined purified thrombin concentrations, turbidimetric fiber thickness measurement, fibrinolysis susceptibility assays\",\n      \"journal\": \"Blood reviews\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro biochemical assays with defined concentrations; review synthesizing multiple experimental studies\",\n      \"pmids\": [\"17208341\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"F2 (prothrombin) is a serine protease zymogen cleaved to thrombin, whose 1.9 Å crystal structure reveals a restricted active-site cleft and a distinct fibrinogen-recognition exosite; thrombin activates platelets and cells via proteolytic unmasking of tethered-ligand receptors PAR1, PAR3, and PAR4, amplifies coagulation by activating Factor XI and the prothrombinase complex, and is redirected by thrombomodulin to activate Protein C (anticoagulant) and TAFI (antifibrinolytic), while thrombin concentration at gelation directly determines fibrin clot architecture and fibrinolytic susceptibility.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"F2 encodes prothrombin (coagulation factor II), a serine protease zymogen central to blood coagulation. Functional polymorphisms in F2, including rs1799963 (G20210A) and rs3136516 (A19911G), are associated with elevated prothrombin activity levels in human carriers [PMID:21239755].\",\n  \"teleology\": [\n    {\n      \"year\": 2011,\n      \"claim\": \"Establishing that common F2 polymorphisms (rs1799963 and rs3136516) have functional consequences on prothrombin activity levels addressed whether genetic variation at this locus alters coagulation factor output in vivo.\",\n      \"evidence\": \"Prothrombin activity assays in genotyped human subjects (SLE patients and controls)\",\n      \"pmids\": [\"21239755\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"Single observational study in a disease cohort without in vitro reconstitution or mechanistic dissection of how each variant alters prothrombin expression or activity\",\n        \"No structural or biochemical basis provided for variant-associated activity changes\",\n        \"Not independently replicated in a general population cohort\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Detailed mechanistic studies of how F2 polymorphisms alter mRNA processing, translation efficiency, or protein function remain uncharacterized in this literature corpus.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No in vitro mutagenesis or reporter assays linking specific variants to mRNA stability or translational output\",\n        \"No structural studies of prothrombin variant proteins\",\n        \"No systematic analysis of variant effects on thrombin catalytic activity or substrate specificity\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [],\n    \"localization\": [],\n    \"pathway\": [],\n    \"complexes\": [],\n    \"partners\": [],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"Prothrombin (F2) is a serine protease zymogen that, upon cleavage to thrombin, serves as the central effector of the coagulation cascade and a multifunctional signaling protease whose substrate specificity is modulated by cofactors and whose concentration at gelation governs fibrin clot architecture. Thrombin's crystal structure reveals a trypsin-like fold with unique insertions—including the 60-loop that restricts the active-site cleft—and an anion-binding fibrinogen-recognition exosite critical for substrate and inhibitor engagement [PMID:2583108, PMID:2374926, PMID:8102368]. Thrombin activates platelets and other cells through proteolytic unmasking of tethered-ligand receptors PAR1, PAR3, and PAR4, and amplifies its own generation via a Factor XI feedback loop [PMID:1672265, PMID:9087410, PMID:9618465, PMID:1652157]. The thrombin–thrombomodulin complex redirects substrate specificity from procoagulant targets to protein C activation (anticoagulant) and TAFI activation (antifibrinolytic), while thrombin concentration at the point of gelation directly determines fibrin fiber thickness and fibrinolytic susceptibility [PMID:2538457, PMID:8663147, PMID:17208341].\",\n  \"teleology\": [\n    {\n      \"year\": 1989,\n      \"claim\": \"Determination of the 1.9 Å crystal structure of alpha-thrombin established the structural basis for its restricted substrate specificity and identified the fibrinogen-recognition exosite, answering how thrombin achieves selectivity despite its trypsin-like fold.\",\n      \"evidence\": \"X-ray crystallography of human alpha-thrombin complexed with D-Phe-Pro-Arg chloromethylketone at 1.92 Å resolution\",\n      \"pmids\": [\"2583108\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis for cofactor-induced substrate switching (e.g., by thrombomodulin) not resolved\",\n        \"No structure of prothrombin zymogen to understand activation conformational changes\"\n      ]\n    },\n    {\n      \"year\": 1989,\n      \"claim\": \"Demonstration that thrombomodulin redirects thrombin from procoagulant substrates to protein C activation established the cofactor-dependent switch between procoagulant and anticoagulant functions of thrombin.\",\n      \"evidence\": \"In vitro enzyme kinetics and endothelial cell surface binding assays measuring protein C activation ± thrombomodulin\",\n      \"pmids\": [\"2538457\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural mechanism by which thrombomodulin alters thrombin's active-site specificity was unknown\",\n        \"Relative contribution of the thrombomodulin pathway in vivo not quantified\"\n      ]\n    },\n    {\n      \"year\": 1990,\n      \"claim\": \"The hirudin–thrombin co-crystal structure mapped the molecular determinants of ultra-high-affinity inhibition, revealing that the fibrinogen-recognition exosite serves as a general substrate/inhibitor docking platform distinct from the catalytic cleft.\",\n      \"evidence\": \"X-ray crystallography of recombinant hirudin–thrombin complex at 2.3 Å resolution\",\n      \"pmids\": [\"2374926\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether endogenous serpins exploit the same exosite for initial docking was unresolved\",\n        \"Dynamics of exosite engagement in solution not captured\"\n      ]\n    },\n    {\n      \"year\": 1991,\n      \"claim\": \"Cloning of PAR1 and the discovery of the tethered-ligand mechanism revealed how thrombin converts a proteolytic event into transmembrane signaling, establishing the paradigm for protease-activated receptor biology.\",\n      \"evidence\": \"Expression cloning in Xenopus oocytes, cleavage-site mutagenesis, and synthetic tethered-ligand peptide agonist assays\",\n      \"pmids\": [\"1672265\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Existence of additional thrombin receptor subtypes not yet known\",\n        \"Downstream G-protein coupling specificity of PAR1 not fully characterized\"\n      ]\n    },\n    {\n      \"year\": 1991,\n      \"claim\": \"Demonstration that thrombin directly activates Factor XI more efficiently than Factor XIIa established a positive feedback loop through which thrombin amplifies its own generation independently of the contact pathway.\",\n      \"evidence\": \"In vitro kinetic comparison of thrombin vs. Factor XIIa activation of Factor XI with purified components\",\n      \"pmids\": [\"1652157\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Physiologic surface cofactors for thrombin-mediated Factor XI activation in vivo not identified\",\n        \"Relative contribution of this feedback loop versus the intrinsic pathway in different vascular beds unclear\"\n      ]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"The thrombin–DNA aptamer co-crystal structure confirmed the fibrinogen-recognition exosite as a druggable surface and revealed an unexpected G-quartet binding mode, providing a structural template for exosite-targeted inhibitor design.\",\n      \"evidence\": \"X-ray crystallography at 2.9 Å with Arg75→Glu mutagenesis confirming functional exosite engagement\",\n      \"pmids\": [\"8102368\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether aptamer binding fully occludes all exosite-dependent substrates was not tested\",\n        \"In vivo pharmacology of aptamer-mediated thrombin inhibition not assessed\"\n      ]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Kinetic characterization of TAFI activation revealed that the thrombin–thrombomodulin complex is the physiologic activator (1250-fold efficiency increase), establishing a direct mechanistic link between thrombin generation and downregulation of fibrinolysis.\",\n      \"evidence\": \"Quantitative enzyme kinetics with purified thrombin, thrombomodulin, and TAFI; fibrinolysis inhibition assays\",\n      \"pmids\": [\"8663147\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Crystal structure of the ternary thrombin–thrombomodulin–TAFI complex not determined\",\n        \"Regulation of TAFI activation under flow conditions in vivo not addressed\"\n      ]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Cloning of PAR3 as a second thrombin receptor extended the tethered-ligand paradigm to multiple receptor subtypes, indicating tissue-specific thrombin signaling.\",\n      \"evidence\": \"Molecular cloning, heterologous expression, phosphoinositide hydrolysis assays, and PAR1 knockout mouse studies\",\n      \"pmids\": [\"9087410\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether PAR3 functions as a signaling receptor or a cofactor for PAR4 in human platelets not resolved\",\n        \"PAR3 downstream signaling pathways incompletely characterized\"\n      ]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Cloning and functional validation of PAR4 completed the inventory of thrombin-activated PARs, demonstrating a third receptor through which thrombin triggers G-protein-coupled signaling via tethered-ligand unmasking.\",\n      \"evidence\": \"cDNA cloning, COS cell expression, R47A mutagenesis abolishing thrombin response, synthetic GYPGQV peptide agonist\",\n      \"pmids\": [\"9618465\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Relative contributions of PAR1 vs. PAR4 to human platelet activation kinetics not quantified\",\n        \"Structural basis for differential thrombin affinity across PAR subtypes unknown\"\n      ]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Establishing that thrombin concentration at the gelation point determines fibrin fiber diameter and fibrinolytic susceptibility linked thrombin generation dynamics directly to clot mechanical and lytic properties.\",\n      \"evidence\": \"In vitro fibrin clot formation with defined thrombin concentrations, turbidimetry, and fibrinolysis assays (review synthesizing multiple studies)\",\n      \"pmids\": [\"17208341\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Molecular mechanism by which thrombin concentration controls lateral fibrin protofibril association not defined\",\n        \"In vivo validation of concentration-dependent clot architecture under physiologic flow not performed\",\n        \"Role of other coagulation factors in modulating this relationship not isolated\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis of the thrombomodulin-induced substrate specificity switch at atomic resolution, the contribution of prothrombin's kringle domains to its zymogen activation mechanism, and the relative signaling outputs of PAR1/PAR3/PAR4 in specific human vascular beds.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No high-resolution structure of full-length prothrombin zymogen on a membrane surface\",\n        \"Integrated quantitative model of thrombin's substrate hierarchy in vivo lacking\",\n        \"PAR subtype-specific signaling in human vascular endothelium not systematically compared\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [1, 3, 4, 6, 7, 8]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0, 3, 4, 6, 8]},\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [3, 7, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 1, 4, 6, 9]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-109582\", \"supporting_discovery_ids\": [0, 1, 4, 5, 6, 9]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 7, 8]}\n    ],\n    \"complexes\": [\n      \"Prothrombinase complex (Factor Xa/Va)\",\n      \"Thrombin–thrombomodulin complex\"\n    ],\n    \"partners\": [\n      \"THBD\",\n      \"F2R\",\n      \"F2RL2\",\n      \"F2RL3\",\n      \"F11\",\n      \"CPB2\",\n      \"PROC\",\n      \"FGA\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}